Theme: Future prospects in Biotechnology for Economic Growth

Industrial Biotechnology 2018
Conference final program

Renowned Speakers

Industrial Biotechnology 2018

Conference Series LLC Ltd extends a warm welcome to Annual Industrial Biotechnology and Bioprocessing Congress during September 17-18, 2018 in San Diego, USA with a theme “Future prospects in Biotechnology for Economic Growth”. Conferenceseries through its Open Access Initiative is committed to making genuine and reliable contributions to the scientific community.

Scope and Importance

Industrial Biotechnology 2018 aims to bring together the Professors, Researchers, scientists, business giants, and technocrats to provide an international forum for the dissemination of original research results, new ideas and practical development and discover advances in the field of biotechnology, management and education in relation to biotechnology as well as a breadth of other topics. The applications of biotechnology include therapeutics, diagnostics, and genetically modified crops for agriculture, processed food, bioremediation, waste treatment, and energy production. Industrial Biotechnology 2018 is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.

This biotech meeting creates a platform for Policy-makers, Scientists, representatives and decision makers in biotechnology to present their latest biotech research and learn about all the important developments in biotechnology research. The applications of biotechnology include therapeutics, diagnostics, and genetically modified crops for agriculture, processed food, bioremediation, waste treatment, and energy production. Industrial Biotechnology 2018 is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. Major topics discussed are Biofuels and Biorefinery, Renewable Chemicals and Biobased Materials, Computational Biomedicine, Bioinformatics and Systems Biology, Molecular Biosensing and Biorobotics, Biomaterials, Biomanufacturing, Bioprocessing.

Conference Series LLC Ltd Organizes 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums, and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology, and Business.

Who can attend?

Industrial Biotechnology 2018 conference brings together individuals who have an interest in different fields of Biotechnology. Target Audience will be personnel from both industrial and academic fields which include; Professors, Researchers, scientists, business giants, CEOs, COOs, Directors, Vice Presidents, Co-directors, Biotechnologists, Managing Directors, Industry Safety Officers, Environmental & Plant Scientists, Doctorates, Professors, Post Doctorate Fellows, Vendors of Consumer Products/ Managers, Pharmaceutical Scientists, Students from the related fields.

Why to Attend???

Biotechnology conferences provide a global platform for exchanging ideas and make us updated about the latest innovations in Industrial Biotechnology and Bioprocessing.  Opportunity to attend the presentations delivered by Eminent Scientists from all over the world.

Benefits:

Accepted abstracts will be published in Journal of Biotechnology & Biomaterials and provided with DOI

Global networking: In transferring and exchanging Ideas

A Unique Opportunity for Advertisers and Sponsors at this International event.

Details of Industrial Biotechnology 2018 in USA:

Conference Series LLC Ltd is organizing Industrial Biotechnology Conference in 2018 at San Diego, USA. We organize Biotechnology Meetings in the fields related to Agriculture Biotechnology & Agro-forestry, Bio manufacturing, Bio refinery, Biofuels, Biochemistry, Protein Engineering, Bioinformatics, Systems Biology, Computational Biomedicine, Biomaterials, Bio polymers, Biosensors, Bioprocessing, Secondary Metabolites, Biotechnology in Vaccine Production, Environmental Biotechnology, Waste Water Management, Enzyme Engineering, Drug Discovery, Fermentation technology, Genetic Engineering, CRISPR/Cas 9 Technology, Industrial, Chemical Biotechnology, Industrial Biotechnology, Nutrigenomics, Microbial Biotechnology, Food Processing, Molecular Bio sensing , Bio robotics, Biomarkers, Molecular Biology, Nano-biotechnology, Bio therapeutics, Petroleum Biotechnology, Green chemicals, Pharmaceutical, Medical Biotechnology, Synthetic, Systems Biotechnology.

 

Conference Name

Place

Date

Industrial Biotechnology 2018

San Diego, California, USA

September 17-18, 2018

 

Biofuels and Biorefinery
 
Advanced biofuels are fuels that can be processed from numerous types of biomass. First generation biofuels are processed from the sugars and vegetable oils formed in arable crops, which can be smoothly extracted applying conventional technology. In comparison, advanced biofuels are made from lignocellulosic biomass or woody crops, agricultural residues or waste, which makes it tougher to extract the requisite fuel. Advanced biofuel technologies have been devised because first generation biofuels manufacture has major limitations. First generation biofuel processes are convenient but restrained in most cases:
Biorefining is the efficient processing of biomass into a wide range of marketable products and energy. By means of co-producing relatively (high) value chemicals (e.g. fine chemicals, pharmaceuticals, polymers) the production costs of secondary energy carriers potentially could become market competitors, especially when biorefining is integrated into the existing chemical, material and power industries. Industrial biorefineries have been identified as the novel route to the creation of a new domestic biobased industry. By producing multiple products; a biorefinery can take advantage of the differences in biomass components and intermediates and maximize the value derived from the biomass feedstock.
  • Second generation biofuels
  • Microbial pathways for advanced biofuels product
  • Synthesis of advanced biofuels
  • Valorization of Biorefinery
  • Lignocellulosic material in biorefinery
  • Integrated biorefinery
  • Biorefining systems
8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.
 
Renewable Chemicals and Biobased Materials

Renewable chemicals are used for increasing the use of renewable resources rather than fossil fuels. Renewable chemicals contain all the chemicals which are produced from renewable feedstock such as microorganisms, biomass (plant, animal, and marine), and agricultural raw materials. Renewable chemicals are utilized in several applications across different Chemical industries such as in food processing, housing, textiles, environment, transportation, hygiene, pharmaceutical, and other applications. Renewable chemicals are mainly available as ketones, alcohols, organic acids, and biopolymers. They are used in surfactants and lubricants, consumer goods, resins, and plastics for environmental purpose.
A bio-based material is a material intentionally made from substances derived from living (or once-living) organisms. These materials are sometimes referred to as biomaterials, but this word also has another meaning. Strictly the definition could include many common materials such as wood and leather, but it typically refers to modern materials that have undergone more extensive processing. Unprocessed materials may be called biotic material. Bio-based materials or biomaterials fall under the broader category of bioproducts or bio-based products which includes materials, chemicals, and energy derived from renewable biological resources.

8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.
 
Computational Biomedicine
 
In order to improve the diagnosis, prediction, and treatment of complex medical diseases a process is developed known as computational biomedicine. Computational biomedicine is the name given to the use of computer-based tools and approaches to simulate and model the human body in health and disease. In the European Union, this new science has become synonymous with the concept of the virtual physiological human (VPH). More specifically, however, the name VPN is given to an ambitious initiative, funded through Framework Seven but building on work funded through earlier frameworks and external initiatives.
  • Modelling
  • Simulation
  • Physiological human
  • Molecular dynamics
  • Image processing

8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.

CRISPR Technologies

Genome editing and the utilization of CRISPR primarily based technologies are expected to revolutionize the assembly of the next generation of bioproducts. DCB12 can focus on the most recent developments within the use of CRISPR/Cas9 and alternative CRISPR primarily based technologies in reference to the development and production of biopharmaceuticals, biochemicals, agricultural crops, and travel applications.

8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.

Bioinformatics and Systems Biology
 
Bioinformatics has become an important part of many areas of biology. In experimental molecular biology, bioinformatics techniques such as image and signal processing allow extraction of useful results from large amounts of raw data. In the field of genetics and genomics, it aids in sequencing and annotating genomes and their observed mutations. It plays a role in the text mining of biological literature and the development of biological and gene ontologies to organize and query biological data. It also plays a role in the analysis of gene and protein expression and regulation. Bioinformatics tools aid in the comparison of genetic and genomic data and more generally in the understanding of evolutionary aspects of molecular biology.
 
Systems biology is the computational and mathematical modeling of complex biological systems. It is a biology-based interdisciplinary field of study that focuses on complex interactions within biological systems, using a holistic approach (holism instead of the more traditional reductionism) to biological research.
  • DNA sequencing
  • Sequence assembly
  • Genome annotation
  • Computational evolutionary biology

8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.

Data Analysis in System Biology

Systems biology is a branch of science that is a field of biology aimed at understanding biological processes at the systems level and developing from dynamic interactions of individual elements operative at multiple spatiotemporal scales. This field considers organic Systems by expeditiously bothering them (organically, hereditarily, or artificially) and perceptive the standard, protein, and academic pathway reactions, incorporating this information; decreases within the expense of manufacturing genomic data have created deoxyribonucleic acid sequencing, RNA-sequence, associated high-throughput screening an undeniably imperative piece of medicine exploration.

  • Next-generation metabolomics
  • Targeted metabolic profiling
  • Data integration pathway analysis
  • Integrating gene expression and metabolomics data

8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.

Molecular Biosensing and Biorobotics
 
A biosensor is an analytical device, used for the detection of an analyte, that combines a biological component with a physicochemical detector. The sensitive biological element (e.g. tissue, microorganisms, organelles, cell receptors, enzymes, antibodies, nucleic acids, etc.) is a biologically derived material or biomimetic component that interacts (binds or recognizes) with the analyte under study. The biologically sensitive elements can also be created by biological engineering. The transducer or the detector element (works in a physicochemical way; optical, piezoelectric, electrochemical, etc.) transforms the signal resulting from the interaction of the analyte with the biological element into another signal (i.e., transduces) that can be more easily measured and quantified.
 
Biorobotics is a term that loosely covers the fields of cybernetics, bionics and even genetic engineering as a collective study. Biorobotics is often used to refer to a real subfield of robotics: studying how to make robots that emulate or simulate living biological organisms mechanically or even chemically. The term is also used in a reverse definition: making biological organisms as manipulatable and functional as robots, or making biological organisms as components of robots. In the latter sense, biorobotics can be referred to as a theoretical discipline of comprehensive genetic engineering in which organisms are created and designed by artificial means. The creation of life from non-living matter, for example, would be robotics. The field is in its infancy and is sometimes known as synthetic biology or bionanotechnology.
  • Antibody/antigen interactions
  • Artificial binding proteins
  • Enzymatic interactions
  • Affinity binding receptors
  • Nucleic acid interactions

8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.

Molecular Biology & Biochemistry

Molecular biology is the branch of biological science that deals with a molecular basis of biological activity including the interactions between the different types of DNA, RNA and proteins and their biosynthesis, and studies how these interactions are regulated. The field overlaps with other areas of biology and chemistry, particularly genetics and biochemistry. It has many applications such as gene searching, molecular mechanisms of diseases and its therapeutic approaches by cloning, expression, and regulation of the gene. Research area includes gene expression, epigenetics and structure, and function of chromatin, RNA processing, functions of non-coding RNAs, transcription. Recently, most advanced researches are going on these topics: Molecular biology, structural mechanism of DNA replication, repair and recombination, Transcription, RNA processing, Post-translational modification, proteomics, Genetic Mutation, Site-directed mutagenesis, Epigenetics, Molecular mechanisms of diseases.

  •   Transcription and Gene Expression
  •   Post-translational modification, proteomics
  •   Mutation, Site-directed mutagenesis
  •   Epigenetics, chromatin structure, and function
  •   Molecular mechanisms of diseases

 

8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.

Drug Discovery and Protein Biotechnology

Drug discovery is the process through which potential new medicines are recognized and comprises an extensive range of scientific disciplines, including biology, chemistry, and pharmacology. The integration of pharmacodynamics and pharmacokinetic parameters in non-clinical pharmacology studies is a key characteristic in drug discovery for efficacy and safety assessment, in the particular for the translation from the non-clinical to  clinical field and process of drug discovery include  the identification of candidates, synthesis, characterization, screening, and assays for therapeutic efficacy whereas modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity, selectivity, efficacy/potency, metabolic stability, and oral bioavailability. The "final product" of drug discovery is a patent on the potential drug.
 
Protein production is the biotechnological process of generating a specific protein. It is typically achieved by the manipulation of gene expression in an organism such that it expresses large amounts of a recombinant gene. This includes the transcription of the recombinant DNA to messenger RNA (mRNA), the translation of mRNA into polypeptide chains, which are ultimately folded into functional proteins and may be targeted to specific subcellular or extracellular locations.
  • Cell-based systems
  • Bacterial systems
  • Corynebacterium
  • Filamentous fungi
  • Non-lytic insect cell expression
8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.
 
Industrial Biotechnology 

Industrial biotechnology is a set of practices that use living cells (such as bacteria, yeast, algae) or component of cells like enzymes, to generate industrial products and processes. Industrial biotechnology can be used to: Create new products, such as plant-based biodegradable plastics; Replace petroleum-based feedstock’s by processing biomass in bio refineries to produce electricity, transport fuels or chemicals; Modify and develop new industrial processes, such as by using enzymes to reduce the amount of harsh chemicals used the textile or pulp and paper industries; Reduce the environmental impact of manufacturing; for example by treating industrial wastewater onsite using biological mediums such as microbes; Industrial biotechnology is one of the most promising new approaches to pollution prevention, resource conservation, and cost reduction. It is often referred to as the third wave in biotechnology. If developed to its full potential, industrial biotechnology may have a larger impact on the world than health care and agricultural biotechnology. It offers businesses a way to reduce costs and create new markets while protecting the environment. Also, since many of its products do not require the lengthy review times that drug products must undergo, it's a quicker, easier pathway to the market. Today, new industrial processes can be taken from lab study to commercial application in two to five years, compared to up to a decade for drugs.

  • Micro-organisms
  • Petrochemical-Based Economy
  • Renewable Chemicals and Biobased Materials
  • Microbial growth curve and growth kinetics
  • Mass transfer relationship and Rheological properties
  • Secondary metabolites and Industrial enzymes
  • Pharmaceutical techniques and drug discovery
  • Bio value added products and Novel Vaccines
  • Industrial Fermentation
8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.

Nano-biotechnology
 
NanoBiotechnology is science, building, and innovation directed at the nanoscale, which is around 1 to 100 nanometers. Nanoscience and nanotechnology are the review and utilization of amazingly little things and can be utilized in the various science fields, for example, chemical science, polymer science, physical science, materials science, and engineering. Today's researchers and engineers are finding a wide range of approaches to intentionally make materials at the nanoscale to exploit their upgraded properties, for example, higher quality, lighter weight, expanded control of light range, and more chemical reactivity than their bigger scale counterparts.
  • Nano Science & Nano Technology
  • NanoMedicine
  • Nano Toxicology
  • Nano Chemistry
  • NanoPharmaceuticals
  • Nano-Biomaterials
  • Nano Metrology
  • Advanced Nanomaterials
  • Nano Biometrics
  • Nano Photonics
8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.

Biomaterials
 
Biomaterials are those substances which are introduced into the body as a part of medical devices for medical purposes. These are having many medical applications such as cancer therapy, artificial ligaments and tendons, orthopedic for joint replacements, bone plates, and ophthalmic applications in contact lenses, for wound healing in the form of surgical sutures, clips, nerve regeneration, in reproductive therapy as breast implants, etc. It is also having some non-medical applications such as to grow cells in culture, assay of blood proteins in laboratories, etc.
  • For cancer therapy
  • For ophthalmic applications
  • For orthopedic applications
  • For musculoskeletal orthopedics and tissues
  • Induced regeneration
  • For breast implants
  • In vascular grafts and embolic devices
  • For vascularization
  • Non-medical applications

8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.

Biomanufacturing 
 
Biomanufacturing is a type of manufacturing or biotechnology that utilizes biological systems to produce commercially important biomaterials and biomolecules for use in medicines, food and beverage processing, and industrial applications. Biomanufacturing products are recovered from natural sources, such as blood, or from cultures of microbes, animal cells, or plant cells grown in specialized equipment. The cells used during the production may have been naturally occurring or derived using genetic engineering techniques.
  • Blood plasma fractionation
  • Cell culture
  • Cell separation, such as filtration and centrifugation
  • Fermentation
  • Homogenization
  • Column chromatography

8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.

Bioprocessing 
 
A bioprocess is a specific process that uses complete living cells or their components (e.g., bacteria, enzymes, chloroplasts) to obtain desired products.Transport of energy and mass is fundamental to many biological and environmental processes. Areas, from food processing to thermal design of building to biomedical devices to pollution control and global warming, require knowledge of how energy and mass can be transported through materials (mass, momentum, heat transfer).
  • Upstream Processing
  • Downstream Processing
  • Gene & Cell Therapy
  • Analytical & Quality

8th World Congress on Plant Science & Genomics July 9-10, 2018 Sydney, Australia; 20th World Congress on Biotechnology and Biotech Industries Meet March 5-7, 2018 London, UK; 7th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK; 6th International Conference on Integrative Biology May 21-23, 2018 Barcelona, Spain; 4th International Conference on Bioscience July 2-3, 2018 Vienna, Austria; 10th International Conference on Genomics and Molecular Biology May 21-23, 2018 Barcelona, Spain; 11th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan ; 4th World Congress on Human Genetics and Genetic Diseases April 23-24, 2018 Dubai, UAE; 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, Japan.

 

Industrial Biotechnology

 

Micro-organisms

 

 

The worldwide biotechnology showcase measure was evaluated at USD 369.62 billion out of 2016. Nearness of space for associations in the area is relied upon to drive critical advance in the business. The organizations are concentrating on the advancement of novel systems and their execution by teaming up with alternate members. Associations, for example, the DBT (Department of Biotechnology) together with government-financed establishments and different self-ruling associations speaking to the biotechnology area elevate subsidizing to help R&D and new item improvement tries.

Ascend sought after for these therapeutics and analytic arrangements on standards of red biotechnology, DNA sequencing, and recombinant innovation is expected to fuel development. Expanding commonness of infections, for example, hepatitis B, malignancy, and another vagrant issue is required to fuel request in this space.

Ascend in the interest for nourishment and agrarian items including sugarcane, rice, beans, and wheat attributable to the developing populace base in U.S., China, and India is relied upon to raise the significance of these items. Likewise, factors, for example, deficiency of water, the low yield of products, bug assaults, and constrained accessibility of horticultural land are urging scientists to take part in broad R&D.

Diminishing costs of DNA sequencing is relied upon to serve this segment as a high effect rendering development driver. It is relied upon to urge scientists and makers to expand R&D activities focused on understanding hereditary varieties and creating remedial answers for constant infections with substantial worldwide predominance, for example, cardiovascular sicknesses, diabetes, and tumor.

The advancement of sequencers and their product, and also the association of governments and joint efforts between these organizations and therapeutic experts, will be of most extreme significance for the achievement of DNA-sequencing innovation.

Application Insights

Wellbeing related applications represented the biggest offer because of the higher utilization of related items in the medicinal services industry. The developing pervasiveness of interminable sicknesses increasing the interest for new medication improvement is one of the key components representing the previously mentioned conclusion. Additionally, developing the interest for customized medicine and biosimilars is likewise anticipated that would drive fragment development amid the gauge time frame.

Bioinformatics is relied upon to witness the speediest development in the coming a very long time as an outcome of considerable improvements in this field. Generous advancements incorporate calculation planning for productive capacity and administration of genomic and proteomic information created through the examinations completed on plant, creature or human genomes.

Biotechnology advertises, by district, 2016 (%)

Innovation Insights

Nanobiotechnology overwhelmed regarding income share in 2016. Nanobiotechnology discovers significant application in sedate conveyance treatments for incessant scatters, for example, growth. It includes the improvement of nanoparticle-based chemotherapeutic medications, gold nanoparticles, and quantum dabs for atomic determination and nanobiosensors which help in optical imaging and medication conveyance. Developing R&D completed in different organizations in finding new roads, for example, microfabricated frameworks and gadgets utilized as a part of the treatment of a few intense diseases is a key driving component of this fragment.

Bioinformatics is relied upon to witness the quickest development in the coming years. Take-up of cloud-based arrangements which adequately and vigorously deal with the parallelization and circulation of information and client code on numerous PC hubs is attributive for assessed development in the bioinformatics-based techniques. The presentation of distributed computing condition for handling NGS created information has assumed an extraordinary part as the main impetus in a current situation.

Local Insights

North America overwhelmed the general market as far as income in 2016 at 44.15%. Nearness of high R&D ventures relating to new medication disclosure and advancement are a few elements ascribing to its extensive offer. The U.S. spends more per capita on social insurance than different nations and has a high development rate among different nations. As per the assessments distributed by OECD Health Statistics in 2014, it has been evaluated that in 2012, U.S. spent almost 16.9% of its GDP towards human services consumption, which is the most noteworthy. The previously mentioned truth underpins the evaluated offer of biotechnology showcase.

Asia Pacific then again, is required to pick up the piece of the pie amid the gauge time frame attributable to the nearness of patient mindfulness, quickly enhancing medicinal services framework and rising social insurance use levels in the developing markets. These business sectors incorporate the creating economies of China and India.

Aggressive Insights

The business is divided in nature. This market includes a few little and rising players alongside entrenched significant players. Some key players in the market are Johnson and Johnson Services, Inc., F. Hoffmann-La Roche Ltd, Pfizer, Merck and Co., and Sanofi. Huge firms are focusing on little firms with a working procedure of securing so as to manage the position in the market. For example, in July 2017, Sanofi declared to procure Protein Sciences, a U.S. based organization which manages the R&D of immunizations, in the second from last quarter of this current year. This securing by the organization went for an expansion of recombinant-based flu immunization to its item portfolio.

Portions Covered in the Report

This report gauges income development at a local and national level and gives an investigation on the most recent patterns and openings in each of the sub-sections from 2014 to 2025. With the end goal of this report, Grand View Research has portioned the biotechnology advertise on the premise of innovation, application, and districts:

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date September 17-18, 2018
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1
Poster Opportunity Closed Click Here to View

Media Partners